AVEO Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
15.00
|
|
Average Rating
|
3.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
4
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.18
|
-0.09
|
0.09
|
50.00%
|
|
2022-06-30
|
-0.28
|
-0.24
|
0.04
|
14.29%
|
|
2022-03-31
|
-0.25
|
-0.30
|
-0.05
|
-20.00%
|
|
2021-12-31
|
-0.29
|
-0.21
|
0.08
|
27.59%
|
|
2021-09-30
|
-0.36
|
-0.30
|
0.06
|
16.67%
|
|
2021-06-30
|
-0.45
|
-0.40
|
0.05
|
11.11%
|
|
2021-03-31
|
-0.55
|
-0.81
|
-0.26
|
-47.27%
|
|
2020-12-31
|
-0.38
|
-0.44
|
-0.06
|
-15.79%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.63
|
|
2021-12-31
|
-1.72
|
|
2020-12-31
|
-1.71
|
|
2019-12-31
|
0.62
|
|
2018-12-31
|
-0.50
|
|
2017-12-31
|
-0.34
|
|
2016-12-31
|
-0.40
|
|
2015-12-31
|
-0.28
|
|
2014-12-31
|
-2.10
|
|
2013-12-31
|
-19.50
|
|
2012-12-31
|
-25.70
|
|
2011-12-31
|
9.90
|
|
2010-12-31
|
-20.90
|